| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |